Ticagrelor-Related Severe Dyspnoea: Mechanisms, Characteristic Features, Differential Diagnosis and Treatment

11Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

With a growing number of patients on ticagrelor therapy after stent implantation, we observe many cases of side effects of the drug, mostly dyspnoea and bradycardia. In our article we present 2 patients, in which the symptoms were particularly severe. Then we describe possible mechanisms of these complications, explain how to carry out differential diagnosis, discuss when to switch ticagrelor to other antiplatelet drug and finally we present the way to deal with the symptoms.

Cite

CITATION STYLE

APA

Krakowiak, A., Kuleta, J., Plech, I., Zarębiński, M., Wojciechowska, M., Wretowski, D., & Cudnoch-Jędrzejewska, A. (2020). Ticagrelor-Related Severe Dyspnoea: Mechanisms, Characteristic Features, Differential Diagnosis and Treatment. Clinical Medicine Insights: Case Reports, 13. https://doi.org/10.1177/1179547620956634

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free